Clinical Trial Update: Lead Evaluation for Defibrillation and Reliability Post Approval Study

View source ↗

Summary

Medtronic is conducting a post-approval study to evaluate the reliability of a defibrillation lead. The study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tachyarrhythmia

Snippet

Sponsor: Medtronic | Conditions: Tachyarrhythmia | Status: ENROLLING_BY_INVITATION